Skip to main content
. Author manuscript; available in PMC: 2018 Mar 28.
Published in final edited form as: Med Care. 2016 Jul;54(7):679–688. doi: 10.1097/MLR.0000000000000541

Table 3.

Out-of-ACO Expenditures for Age-Eligible and Non-Age-Eligible Beneficiaries.

Non-Age-Eligible Population Age-Eligible Population
Out-of-ACO dollars spent, over entire sample (unconditional results) Out-of-ACO dollars spent, over entire sample (unconditional results)
Race/ethnicity
Caucasian (reference)* 8301 4899.685
(7589, 9014) (4769, 5031)
 African American** −831 1365
(−3014, 1120) (1987, −501)
 Asian 2397 966
(5529, −19) (1576, −222)
 Latino 226 −193
(−2148, 3030) (−1637, 1643)
 Other Race/Ethnicity 348 1216
(−3516, 5293) (1788, −522)
Sex
Male (reference) 8303 4664
(7592,9014) (4534, 4794)
 Female −423 −49
(−2493, 958) (−467, 336)
Income (tens of thousands)
Quintile 1 (reference) 7141 4530
(6511, 7772) (4404, 4656)
 Quintile 2 1841 −194
(−451, 6534) (−877, 446)
 Quintile 3 1055 41
(−966, 4220) (−724, 710)
 Quintile 4 1848 399
(−89, 5441) (−298, 1026)
 Quintile 5 3862 428
(−387, 14421) (−293, 1162)
Distance (miles)
0-9 (reference) 6969 4489
(6380, 7557) (4364, 4614)
 10-19 1647 285
(−95, 5372) (−238, 801)
 20-29 13 101
(−2087, 2582) (−657, 995)
 30+ 3176 1196
(972, 7994) (419, 2067)
Dual-eligible
No (reference) 9775 4860
(8922, 10627) (4723, 4997)
 Yes 2756 1061
(5788, −1017) (1566, −488)
Employer-based Insurance
No (reference) 8131 4733
(7433, 8830) (4603, 4863)
 Yes −3011 1876
(−6431, 29) (2565, −837)
Hypertension
No (reference) 4507 3992
(4187, 4827) (3885, 4098)
Yes 5230 860
(3605, 7903) (496, 1247)
Hyperlipidemia
No (reference) 9022 4364
(8215, 9829) (4247, 4482)
Yes −1666 487
(−5099, 55) (98, 859)
Coronary Artery Disease
No (reference) 7044 4114
(6490, 7597) (4012, 4216)
Yes 3416 1556
(−32, 8278) (1077, 2062)
Mental Health
No (reference) 6231 4188
(5713, 6749) (4088, 4289)
Yes 6124 2084
(3771, 9455) (1443, 2674)
Dementia
No (reference) 4187
(4087, 4287)
Yes 2674
(1829, 3780)
Osteoarthritis
No (reference) 7346 3731
(6732, 7959) (3639, 3823)
Yes 2263 2158
(564, 4403) (1739, 2582)
Rheumatoid Arthritis
No (reference) 7944 4571
(7258,8630) (4448,4695)
Yes 1389 2519
(−1537, 5849) (1343,4040)
Cancer (non-skin)
No (reference) 6856 3586
(6294, 7417) (3494, 3678)
Yes 3649 2329
(1674, 7279) (1901, 2751)
COPD
No (reference) 7322 4195
(6697, 7947) (4090, 4301)
Yes 2740 1912
(465, 5961) (1289, 2517)
Congestive Health Failure
No (reference) 7311 4237
(6732, 7890) (4137, 4337)
Yes 3234 1871
(131, 7643) (1017, 2850)
Atrial Fibrillation
No (reference) 7421 4293
(6808, 8035) (4183, 4403)
Yes 2121 1062
(−79, 4905) (549, 1562)
ESRD
No (reference) 5573 4379
(5207, 5939) (4268, 4490)
Yes 8511 1454
(5009, 12697) (751, 2147)
Stroke
No (reference) 6945 4082
(6413,7477) (3985, 4178)
Yes 5600 2219
(2674, 9940) (1589, 2928)
Peripheral Vascular Disease
No (reference) 7401 4289
(6810, 7992) (4182, 4397)
Yes 2874 1778
(−159, 6846) (1061, 2551)
Diabetes
No (reference) 6978 4406
(6403, 7553) (4289, 4523)
Yes 2536 970
(514, 5430) (463, 1458)
Schizophrenia
No (reference) 7317 4608
(6687,7948) (4485, 4731)
Yes 7896 1102
(4137, 14183) (−111, 2548)
Thyroid disorder
No (reference) 7899 4439
(7220, 8579) (4321, 4557)
Yes 579 876
(−1340, 2540) (410, 1400)
*

Values for the reference group show the predicted probabilities and predicted means.

**

Values for the non-reference groups show the marginal effects (the adjusted differences between that group and the reference group).